Clinical Trial

Stereotactic Radiotherapy Combined With Chemotherapy or Not for Treatment of Oligometastases in HNSCC

Study acronym: OMET
Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated September 2, 2025 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
The aim of this study is to evaluate the rate of living patients at 1 year with a quality of life criteria (no decrease) and reduced toxicities. This criteria will be compared in both groups., A cost effectiveness study is scheduled also.
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2017-02-28; most recent amendment 2025-08-28.
Status change: Recruiting → Active, Not Recruiting 2023-06-19
Trial Details
NCT Number NCT03070366
Lead Sponsor Groupe Oncologie Radiotherapie Tete et Cou
Conditions Head and Neck Squamous Cell Carcinoma
Enrollment 78 participants
Start Date 2015-09-21
Primary Completion 2026-07 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2025-09-02